| ARTICLES |
|
| Year : 1997 | Volume
: 3
| Issue : 1 | Page : 3-7 |
|
|
Vasoactive drugs in the management of acute variceal bleeding
Michel Beauchant
Hepatology Unit, BP 577 86021, CHU Poitiers, France
Correspondence Address:
Michel Beauchant
Hepatology Unit, BP 577 86021, CHU Poitiers
France
 Source of Support: None, Conflict of Interest: None  | Check |
PMID: 19864806 
|
|
|
Several methods have been used to treat acute variceal hemorrhage. Sclerotherapy is the method of choice. The use of vasoactive drugs is popular despite unsatisfactory effect and systemic hemodynamic adverse effects. The recently introduced longacting somatostatin analogue, octreotide, is more effective and has no systemic adverse effects. It may be used while waiting for emergency sclerotherapy or in combination with sclerotherapy in patients with high risk of rebleeding. |
|
|
|
| [FULL TEXT] [PDF Not available]* |
|
 |
|
